(Q40018547)

16 September 2017

title

Effect of silymarin supplement on the pharmacokinetics of rosuvastatin (English)

1 reference

16 September 2017

1 reference

Jian Wei Deng

1

1 reference

16 September 2017

Ji-Hong Shon

2

1 reference

16 September 2017

Ho-Jung Shin

3

1 reference

16 September 2017

Soo-Jin Park

4

1 reference

16 September 2017

Chang-Woo Yeo

5

1 reference

16 September 2017

Hong-Hao Zhou

6

1 reference

16 September 2017

Im-Sook Song

7

1 reference

16 September 2017

Jae-Gook Shin

8

1 reference

16 September 2017

publication date

31 January 2008

1 reference

16 September 2017

published in

Pharmaceutical Research

1 reference

16 September 2017

volume

25

1 reference

16 September 2017

issue

8

1 reference

16 September 2017

page(s)

1807-1814

1 reference

Effect of the flavonoids biochanin A and silymarin on the P-glycoprotein-mediated transport of digoxin and vinblastine in human intestinal Caco-2 cells

16 September 2017

cites work

1 reference

12 December 2020

The flavonoids. A class of semi-essential food components: their role in human nutrition

1 reference

12 December 2020

Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics of Atorvastatin and Rosuvastatin

1 reference

12 December 2020

Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance

1 reference

12 December 2020

The effect of gemfibrozil on the pharmacokinetics of rosuvastatin

1 reference

12 December 2020

Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein

1 reference

12 December 2020

[The solubility and bioequivalence of silymarin preparations]

1 reference

12 December 2020

Silymarin treatment of viral hepatitis: a systematic review

1 reference

12 December 2020

C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance.

1 reference

12 December 2020

Role of organic anion transporter OATP1B1 (OATP-C) in hepatic uptake of irinotecan and its active metabolite, 7-ethyl-10-hydroxycamptothecin: in vitro evidence and effect of single nucleotide polymorphisms.

1 reference

12 December 2020

Optimizing the pharmacology of statins: characteristics of rosuvastatin

1 reference

12 December 2020

Flavonoids chrysin and benzoflavone, potent breast cancer resistance protein inhibitors, have no significant effect on topotecan pharmacokinetics in rats or mdr1a/1b (-/-) mice.

1 reference

12 December 2020

Improvement of the dissolution rate of silymarin by means of solid dispersions

1 reference

12 December 2020

Rosuvastatin demonstrates greater reduction of low-density lipoprotein cholesterol compared with pravastatin and simvastatin in hypercholesterolaemic patients: a randomized, double-blind study.

1 reference

12 December 2020

Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males

1 reference

12 December 2020

Influence of OATP1B1 genotype on the pharmacokinetics of rosuvastatin in Koreans.

1 reference

12 December 2020

Pharmacokinetic studies with silymarin in human serum and bile.

1 reference

12 December 2020

A review of Silybum marianum (milk thistle) as a treatment for alcoholic liver disease

1 reference

12 December 2020

Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and atpase activities by interaction with dietary flavonoids

1 reference

12 December 2020

Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics.

1 reference

12 December 2020

Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance.

1 reference

12 December 2020

Flavonoids as a novel class of human organic anion-transporting polypeptide OATP1B1 (OATP-C) modulators

1 reference

12 December 2020

Interaction of the breast cancer resistance protein with plant polyphenols

1 reference

12 December 2020

Combined effects of multiple flavonoids on breast cancer resistance protein (ABCG2)-mediated transport

1 reference

12 December 2020

Comparative bioavailability of silibinin in healthy male volunteers.

1 reference

12 December 2020

Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain

1 reference

12 December 2020

Softgel capsule technology as an enhancer device for the absorption of natural principles in humans. A bioavailability cross-over randomised study on silybin

1 reference

12 December 2020

Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions

1 reference

12 December 2020

ATP-dependent transport of rosuvastatin in membrane vesicles expressing breast cancer resistance protein

1 reference

12 December 2020

10.1007/S11095-007-9492-0

Identifiers

DOI

1 reference

16 September 2017

1 reference